Institutional investors purchased a net $1.3 million shares of GERN during the quarter ended March 2013 and now own 35.44% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 3.0 Million shares of Geron Corp
BLACKROCK FUND ADVISORS Bought 769.8 Thousand shares of Geron Corp
FIRST EAGLE INVESTMENT MANAGEMEN... Bought 650.0 Thousand shares of Geron Corp